VF
XERS icon

Virtu Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Virtu Financial’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,137
Closed -$58K – 2122
2024
Q4 		$58K Buy
+17,137
New +$55.1K ﹤0.01% 1139
2023
Q3 		– Sell
-80,416
Closed -$211K – 1984
2023
Q2 		$211K Buy
80,416
+48,918
+155% +$125K 0.02% 786
2023
Q1 		$51K Buy
+31,498
New +$39.4K 0.01% 1093
2022
Q4 		– Sell
-18,180
Closed -$28K – 2203
2022
Q3 		$28K Sell
18,180
-38,379
-68% -$63.5K ﹤0.01% 1337
2022
Q2 		$87K Buy
56,559
+5,556
+11% +$11.7K 0.01% 983
2022
Q1 		$131K Buy
+51,003
New +$125K 0.01% 912
2021
Q3 		– Sell
-11,820
Closed -$48K – 2020
2021
Q2 		$48K Buy
+11,820
New +$45.1K ﹤0.01% 1339

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Virtu Financial's XERS Position: Q1 2025 in Review

Virtu Financial sold out of Xeris Biopharma Holdings (XERS) in Q1 2025, closing a stake of 17,137 shares — an estimated $58K sold.

Virtu Financial first reported a position in XERS in Q2 2021 and held it in 7 quarters. The position peaked at $211K in Q2 2023. 199 funds tracked by Wall St. Rank hold XERS as of Q1 2025.

  • Virtu Financial reported no remaining Xeris Biopharma Holdings position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 17,137 Xeris Biopharma Holdings shares in Q1 2025, an estimated $58K.
  • Virtu Financial first reported a position in Xeris Biopharma Holdings in Q2 2021 and held it in 7 quarters.
  • Virtu Financial's Xeris Biopharma Holdings position peaked at $211K in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.